No, not a significant fail, nobody expects anything to work in pancreatic anyway.
I suspect, but am not going to confirm because I don't have time, that they are studying it in multiple solid tumor types. If this is the case, pancreatic would be the first to report out for obvious reasons.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.